Spyware Doctor 5.5 Launched
* Reuters is not responsible for the content in this press release.
Latest Release Improves on Multi-Award Winning Product Providing
the Most Advanced Anti-Spyware Product on Market
SAN FRANCISCO--(Business Wire)--PC Tools today announced the launch of the latest release of
multi-award winning Spyware Doctor(R), Version 5.5. Building on the
success of Spyware Doctor 5, Version 5.5 has been upgraded to provide
minimal impact to computer performance and user-friendly
functionality.
New features include enhanced rootkit detection and removal,
enhanced real-time protection at the kernel level, reduced memory
usage, network guard enhancements and automated threat evaluation.
"PC Tools has recognized the inability of most anti-spyware
products to provide consumers with an advanced, yet user-friendly
offering that provides superior protection and reduces both user
interaction and memory usage," said Simon Clausen, Chief Executive
Officer, PC Tools. "We are confident that the latest release of
Spyware Doctor meets these objectives and continues to be the most
advanced product on the market."
Consistently awarded Editor's Choice awards by leading PC
magazines and testing laboratories worldwide and downloaded by over a
hundred million users globally, Spyware Doctor continues to detect,
remove and block all types of malware including spyware, adware,
spyware Trojans, rootkits, keyloggers and a variety of other security
related risks. OnGuard real-time protection also protects the user
from malicious phishing websites.
Spyware Doctor 5.5 provides:
-- Enhanced Rootkit Removal - Spyware Doctor 5.5 now has upgraded
rootkit removal techniques that reduce the number of system
reboots previously required to remove some of the most
difficult rootkits.
-- Improved Real-time Kernel Level Protection - Unlike previous
versions, the OnGuard real-time protection in Spyware Doctor
5.5 now can make decisions on threats earlier, at the kernel
level, to help improve performance.
-- Reduced Memory Usage - The overall memory usage and footprint
for Spyware Doctor 5.5 has been reduced to ensure minimal
impact to computer performance.
-- Network Guard Enhancement - Network Guard has been upgraded to
include additional protection against new threats that attack
network registry settings, thus preventing them from
interfering with your Internet connection.
-- Intelli-risk Rating - In previous versions of Spyware Doctor,
unnecessary warnings may have occurred with inactive traces of
threats rated as high risk. Now in Spyware Doctor 5.5, the
intelli-risk rating system ranks threats by rating inactive
traces of threats detected according to the actual risk posed.
-- Automated Threat Evaluation - Spyware Doctor 5.5 now
incorporates automatic threat evaluation, providing
standardized descriptions that allow easy differentiation and
understand detected threats.
Standard features include:
-- Free 24-hour customer support for all users
-- Frequent advanced updates to ensure constant protection
-- Detects and removes all types of Spyware and Adware threats
Spyware Doctor Full Version Information
Operating System: Designed for Windows Vista(R), XP and 2000
Recommended Retail Price: $29.95 (US)
NOTE TO EDITOR
If would like to trial or review Spyware Doctor 5.5, please
contact Sayo Ogundiran (details below).
ABOUT PC TOOLS
PC Tools is a global software leader with a cache of security and
utility products, including the multi award-winning Spyware Doctor. PC
Tools is an industry leader in real-time anti-spyware and has a number
of key patents pending.
The PC Tools Malware Research Centre monitors trends and emerging
spyware issues and provides security solutions for the consumer and
enterprise marketplace. The company is headquartered in Sydney, with
offices in San Francisco, London, Shannon (Ireland), Melbourne, Kiev,
and Boulder. PC Tools has a global network of distributors, resellers,
and retailers.
Monument PR Worldwide for PC Tools
Sayo Ogundiran
Office: 415-547-1817
Mobile: 650-906-1956
sayoo@monumentpr.com
Copyright Business Wire 2008
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.



Follow Reuters